From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,044,054 shares, representing 7.74% for $24.7 million under the buyback announced on November 6, 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.96 USD | 0.00% |
|
+0.05% | +15.43% |
06-10 | Surmodics Signs Group Purchasing Deal With Premier | MT |
06-10 | Surmodics, Inc. Receives Thrombectomy Products Agreement with Premier, Inc | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.43% | 598M | |
-4.72% | 182B | |
-2.83% | 103B | |
-5.01% | 66.94B | |
+15.53% | 46.73B | |
-8.53% | 45.14B | |
+5.90% | 41.57B | |
+17.67% | 30.48B | |
+13.37% | 24.26B | |
-8.08% | 23.58B |
- Stock Market
- Equities
- SRDX Stock
- News Surmodics, Inc.
- Tranche Update on Surmodics, Inc.'s Equity Buyback Plan announced on November 6, 2014.